drugset

drugset / Trial / NCT02866214

Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.

NCT02866214 ↗

Phase 2/3 Completed 57 enrolled Ain Shams University

RandomizedParallel-groupTriple-blindTreatment

Summary

The Purpose of this study is to determine if the Febuxostat has an effect on endothelial dysfunction on hemodialysis patients.

Timeline

Start: 2016-08
Primary completion: 2016-10
Completion: 2016-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Febuxostat	Small molecule	40 mg	—

Indications